Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxNotes PayablesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

1606 (CBDW) Cash & Equivalents (2021 - 2025)

1606 has reported Cash & Equivalents over the past 5 years, most recently at $998.0 for Q3 2025.

  • Quarterly Cash & Equivalents fell 96.27% to $998.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $998.0 through Sep 2025, down 96.27% year-over-year, with the annual reading at $2078.0 for FY2024, 95.75% down from the prior year.
  • Cash & Equivalents was $998.0 for Q3 2025 at 1606, down from $1863.0 in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $220111.0 in Q1 2023 and troughed at $285.0 in Q1 2025.
  • The 5-year median for Cash & Equivalents is $15871.0 (2024), against an average of $33323.3.
  • Year-over-year, Cash & Equivalents soared 2441.11% in 2023 and then plummeted 98.2% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $9543.0 in 2021, then soared by 1000.96% to $105065.0 in 2022, then crashed by 53.42% to $48941.0 in 2023, then plummeted by 95.75% to $2078.0 in 2024, then plummeted by 51.97% to $998.0 in 2025.
  • Per Business Quant, the three most recent readings for CBDW's Cash & Equivalents are $998.0 (Q3 2025), $1863.0 (Q2 2025), and $285.0 (Q1 2025).